Literature DB >> 33535173

Identification of hub genes and key pathways in the emphysema phenotype of COPD.

Qiunan Zuo1,2, Youyu Wang3, Deqing Yang1, Shujin Guo2, Xiaohui Li2, Jiajia Dong1, Chun Wan1, Yongchun Shen1, Fuqiang Wen1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition associated with high morbidity and mortality. This study aimed to use weighted gene co-expression network analysis (WGCNA) to explore the molecular pathogenesis of the emphysema phenotype of COPD. After obtaining lung mRNA expression profiles from ten patients with the emphysema phenotype of COPD and eight controls, emphysema-associated gene modules were identified with WGCNA. Among 13 distinct modules, the green-yellow and brown modules showed the strongest correlations with emphysema severity and lung function and were thus selected as hub modules. On gene ontology analysis, these two modules were mainly enriched in immune response, B cell receptor (BCR) signaling pathway, extracellular matrix (ECM) organization, and collagen fibril organization. Pathway analysis primarily showed enrichment in BCR signaling pathways, ECM receptor interaction, and NF-κB and TGF-β signaling pathways for the two hub modules. Several genes, including FCRLA, MS4A1, CD19, FKBP10, C1S and HTRA1, among others, were identified as hub genes. Our results shed light on the potential genetic mechanisms underlying the pathogenesis of the emphysema phenotype of COPD. However, further research will be needed to confirm the involvement of the identified genes and to determine their therapeutic relevance.

Entities:  

Keywords:  chronic obstructive pulmonary disease; emphysema; weighted gene co-expression network analysis

Year:  2021        PMID: 33535173      PMCID: PMC7950259          DOI: 10.18632/aging.202432

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  43 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 2.  The MS4A family: counting past 1, 2 and 3.

Authors:  Li Eon Kuek; Melanie Leffler; Graham A Mackay; Mark D Hulett
Journal:  Immunol Cell Biol       Date:  2015-04-03       Impact factor: 5.126

3.  Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease.

Authors:  Belén Núñez; Jaume Sauleda; Josep Maria Antó; Maria Rosa Julià; Mauricio Orozco; Eduard Monsó; Aina Noguera; Federico P Gómez; Judith Garcia-Aymerich; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2010-11-19       Impact factor: 21.405

Review 4.  [Weighted gene co-expression network analysis in biomedicine research].

Authors:  Wei Liu; Li Li; Hua Ye; Wei Tu
Journal:  Sheng Wu Gong Cheng Xue Bao       Date:  2017-11-25

5.  Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).

Authors:  José Luis Izquierdo-Alonso; Jose Miguel Rodriguez-Gonzálezmoro; Pilar de Lucas-Ramos; Irune Unzueta; Xabier Ribera; Esther Antón; Antonio Martín
Journal:  Respir Med       Date:  2013-02-16       Impact factor: 3.415

Review 6.  Current Approaches for Phenotyping as a Target for Precision Medicine in COPD Management.

Authors:  Jose Luis Lopez-Campos; Stefano Centanni
Journal:  COPD       Date:  2018-03-20       Impact factor: 2.409

7.  Fibrillin-1 staining anomalies are associated with increased staining for TGF-beta and elastic fibre degradation; new clues to the pathogenesis of emphysema.

Authors:  Mieke M J F Koenders; Ronnie G Wismans; Barry Starcher; Ben C J Hamel; Richard P N Dekhuijzen; Toin H van Kuppevelt
Journal:  J Pathol       Date:  2009-08       Impact factor: 7.996

Review 8.  Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.

Authors:  Corry-Anke Brandsma; Maarten Van den Berge; Tillie-Louise Hackett; Guy Brusselle; Wim Timens
Journal:  J Pathol       Date:  2019-12-03       Impact factor: 7.996

9.  Differential coexpression networks in bronchiolitis and emphysema phenotypes reveal heterogeneous mechanisms of chronic obstructive pulmonary disease.

Authors:  Jiangyue Qin; Ting Yang; Ni Zeng; Chun Wan; Lijuan Gao; Xiaoou Li; Lei Chen; Yongchun Shen; Fuqiang Wen
Journal:  J Cell Mol Med       Date:  2019-08-16       Impact factor: 5.310

10.  PRMT6 mediates inflammation via activation of the NF-κB/p65 pathway on a cigarette smoke extract-induced murine emphysema model.

Authors:  Xue He; Tiao Li; Lijuan Luo; Huihui Zeng; Yan Chen; Shan Cai
Journal:  Tob Induc Dis       Date:  2020-02-04       Impact factor: 2.600

View more
  3 in total

1.  Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Huijie Wang; Yonghong Zhong; Na Li; Min Yu; Lin Zhu; Lina Wang; Fei Chen; Yaping Xu; Jian Liu; Huaqiong Huang
Journal:  Respir Res       Date:  2022-02-12

2.  CD19 and POU2AF1 are Potential Immune-Related Biomarkers Involved in the Emphysema of COPD: On Multiple Microarray Analysis.

Authors:  Da-Wei Zhang; Jing-Jing Ye; Ying Sun; Shuang Ji; Jia-Ying Kang; Yuan-Yuan Wei; Guang-He Fei
Journal:  J Inflamm Res       Date:  2022-04-20

3.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.